These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25825053)

  • 1. Plaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography.
    Zhang MD; Zhao XC; Zhang YH; Yan YF; Wang ZM; Lv SZ; Zhao QM
    Cardiovasc Ther; 2015 Jun; 33(3):118-26. PubMed ID: 25825053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
    Vucic E; Dickson SD; Calcagno C; Rudd JH; Moshier E; Hayashi K; Mounessa JS; Roytman M; Moon MJ; Lin J; Tsimikas S; Fisher EA; Nicolay K; Fuster V; Fayad ZA
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1100-9. PubMed ID: 21999870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pioglitazone on inflammation and calcification in atherosclerotic rabbits : An
    Xu J; Nie M; Li J; Xu Z; Zhang M; Yan Y; Feng T; Zhao X; Zhao Q
    Herz; 2018 Dec; 43(8):733-740. PubMed ID: 28956073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
    Mizoguchi M; Tahara N; Tahara A; Nitta Y; Kodama N; Oba T; Mawatari K; Yasukawa H; Kaida H; Ishibashi M; Hayabuchi N; Harada H; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1110-8. PubMed ID: 21999871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
    Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography.
    Patel R; Janoudi A; Vedre A; Aziz K; Tamhane U; Rubinstein J; Abela OG; Berger K; Abela GS
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2007-14. PubMed ID: 21817102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) in evaluating the stability of atherosclerotic plaques].
    Zhang YH; Tian P; Xu JP; Wang ZZ; Zhao XZ; Nie MX; Zhang MD; Zhao QM; Zhao BT; Song SJ
    Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):808-813. PubMed ID: 31665855
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring of atherosclerosis evolution by detection of inflammatory states of aortae in a rabbit model using 18F-FDG -PET/CT.
    Zhao QM; Zhao X; Feng TT; Zhang MD; Zhuang XC; Zhao XC; Zhang XX; Su G
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):440-50. PubMed ID: 24518191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography.
    Aziz K; Berger K; Claycombe K; Huang R; Patel R; Abela GS
    Circulation; 2008 Apr; 117(16):2061-70. PubMed ID: 18391115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
    Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
    J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance.
    Yang HB; Zhao XY; Zhang JY; Du YY; Wang XF
    Diabet Med; 2012 Mar; 29(3):359-65. PubMed ID: 21950726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noninvasive imaging of vulnerable plaques and thromboses with PET/CT complex imaging technique].
    Zhao X; Zhao QM; Feng TT; Li DP; Liu Y; Li LQ; Zhang MD; Zhuang XC; Zhao XC
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1454-7. PubMed ID: 24029566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of vulnerable atherosclerotic plaque and prediction of thrombosis events in a rabbit model using 18F-FDG -PET/CT.
    Zhao QM; Zhao X; Feng TT; Zhang MD; Zhuang XC; Zhao XC; Li LQ; Li DP; Liu Y
    PLoS One; 2013; 8(4):e61140. PubMed ID: 23613798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.
    Ogawa M; Magata Y; Kato T; Hatano K; Ishino S; Mukai T; Shiomi M; Ito K; Saji H
    J Nucl Med; 2006 Nov; 47(11):1845-50. PubMed ID: 17079818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
    Calcagno C; Lairez O; Hawkins J; Kerr SW; Dugas MS; Simpson T; Epskamp J; Robson PM; Eldib M; Bander I; K-Raman P; Ramachandran S; Pruzan A; Kaufman A; Mani V; Ehlgen A; Niessen HG; Broadwater J; Fayad ZA
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):291-301. PubMed ID: 29413439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
    Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA
    Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin.
    Vucic E; Calcagno C; Dickson SD; Rudd JH; Hayashi K; Bucerius J; Moshier E; Mounessa JS; Roytman M; Moon MJ; Lin J; Ramachandran S; Tanimoto T; Brown K; Kotsuma M; Tsimikas S; Fisher EA; Nicolay K; Fuster V; Fayad ZA
    JACC Cardiovasc Imaging; 2012 Aug; 5(8):819-28. PubMed ID: 22897996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.
    Tahara N; Kai H; Ishibashi M; Nakaura H; Kaida H; Baba K; Hayabuchi N; Imaizumi T
    J Am Coll Cardiol; 2006 Nov; 48(9):1825-31. PubMed ID: 17084257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of rupture of atherosclerotic plaque by Candesartan in rabbit model].
    Zhou XF; Yin HC; Zhu WL; Shen L; Yu T; Li SA; Meng ZM; Wu AS; Qian HD
    Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):106-11. PubMed ID: 20388376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.